We Think Biotechnology Assets (BME:BST) Has A Fair Chunk Of Debt
Nov 14
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedNov 24, 2024
DataAggregated Company Financials
Companies14
- 7D-2.0%
- 3M2.6%
- 1Y-1.6%
- YTD-10.6%
Over the last 7 days, the Healthcare industry has dropped 2.0%, driven by a pullback from Grifols of 4.7%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 34% per annum.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 24 Nov 2024 | €15.4b | €10.5b | €393.8m | 19.5x | 39.1x | 1.5x |
| Tue, 22 Oct 2024 | €16.0b | €10.2b | €394.8m | 16.5x | 40.6x | 1.6x |
| Thu, 19 Sep 2024 | €15.2b | €10.2b | €399.9m | 15.7x | 38x | 1.5x |
| Sat, 17 Aug 2024 | €14.0b | €10.2b | €399.9m | 15.2x | 35.1x | 1.4x |
| Mon, 15 Jul 2024 | €15.8b | €10.0b | €405.9m | 19.8x | 39x | 1.6x |
| Wed, 12 Jun 2024 | €15.3b | €10.0b | €405.9m | 21x | 37.6x | 1.5x |
| Fri, 10 May 2024 | €14.6b | €10.0b | €266.6m | 17.6x | 55x | 1.5x |
| Sun, 07 Apr 2024 | €14.1b | €10.0b | €292.0m | 21.2x | 48.4x | 1.4x |
| Tue, 05 Mar 2024 | €13.3b | €10.0b | €289.0m | 20.7x | 45.9x | 1.3x |
| Thu, 01 Feb 2024 | €14.3b | €10.0b | €332.5m | 17.7x | 43.1x | 1.4x |
| Sat, 30 Dec 2023 | €17.2b | €10.0b | €332.6m | 17.3x | 51.6x | 1.7x |
| Mon, 27 Nov 2023 | €15.4b | €10.0b | €332.5m | 17.4x | 46.5x | 1.5x |
| Wed, 25 Oct 2023 | €13.4b | €9.8b | €302.1m | 17.5x | 44.4x | 1.4x |
| Fri, 22 Sep 2023 | €15.1b | €9.8b | €311.0m | 19.2x | 48.7x | 1.6x |
| Sun, 20 Aug 2023 | €15.4b | €9.8b | €311.0m | 19.8x | 49.5x | 1.6x |
| Tue, 18 Jul 2023 | €14.1b | €9.6b | €364.7m | 20.2x | 38.6x | 1.5x |
| Thu, 15 Jun 2023 | €13.8b | €9.6b | €364.6m | 20.7x | 37.8x | 1.4x |
| Sat, 13 May 2023 | €13.5b | €9.3b | €533.7m | 21.1x | 25.4x | 1.5x |
| Mon, 10 Apr 2023 | €12.4b | €9.3b | €563.7m | 18.9x | 22.1x | 1.3x |
| Wed, 08 Mar 2023 | €13.6b | €9.3b | €564.2m | 20.2x | 24.2x | 1.5x |
| Fri, 03 Feb 2023 | €15.2b | €8.4b | €430.6m | 13.7x | 35.4x | 1.8x |
| Sun, 01 Jan 2023 | €13.7b | €8.4b | €430.6m | 13.7x | 31.9x | 1.6x |
| Tue, 29 Nov 2022 | €13.6b | €8.4b | €431.4m | 14.5x | 31.6x | 1.6x |
| Thu, 27 Oct 2022 | €12.9b | €8.4b | €462.3m | 13.4x | 27.9x | 1.5x |
| Sat, 24 Sep 2022 | €13.4b | €8.3b | €461.7m | 13.7x | 29.1x | 1.6x |
| Mon, 22 Aug 2022 | €16.1b | €8.3b | €465.4m | 14.4x | 34.5x | 1.9x |
| Wed, 20 Jul 2022 | €18.6b | €7.9b | €514.1m | 14.5x | 36.1x | 2.3x |
| Fri, 17 Jun 2022 | €18.5b | €7.9b | €513.8m | 13.6x | 36.1x | 2.3x |
| Sun, 15 May 2022 | €20.6b | €7.8b | €485.6m | 14.3x | 42.3x | 2.6x |
| Tue, 12 Apr 2022 | €19.4b | €7.8b | €487.8m | 14.4x | 39.8x | 2.5x |
| Thu, 10 Mar 2022 | €19.0b | €7.8b | €506.8m | 13.8x | 37.6x | 2.5x |
| Sat, 05 Feb 2022 | €18.5b | €7.9b | €932.5m | 16.3x | 19.9x | 2.4x |
| Mon, 03 Jan 2022 | €19.7b | €7.9b | €932.0m | 17.3x | 21.1x | 2.5x |
| Wed, 01 Dec 2021 | €18.4b | €7.8b | €911.8m | 17.1x | 20.2x | 2.4x |
Price to Earnings Ratio
20.2x
Current Industry PE
- Investors are relatively neutral on the Spanish Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 36.7x.
- The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 24% per year over the last three years.
- Meanwhile revenues for these companies have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 0.36% | |
| Healthcare | -2.01% | |
| Life Sciences | 2.87% | |
| Medical Equipment | 1.63% | |
| Pharma | 0.76% | |
| Healthtech | 0% | |
| Healthcare Services | -2.23% | |
| Biotech | -4.19% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 43.8x.
- Analysts are expecting annual earnings growth of 94.3%, which is higher than its past year's earnings growth of 22.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 94% over the next 5 years.
- This is better than its past earnings growth rate of 22% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 26% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROVI Laboratorios Farmaceuticos Rovi | €63.00 | 1.4% +€43.5m | 14.3% | PE19.5x | |
| ALM Almirall | €8.47 | 1.3% +€23.5m | 1.4% | PS1.9x | |
| PRM Prim | €10.00 | 1.6% +€2.7m | -4.8% | PE14.9x | |
| PANG Pangaea Oncology | €1.79 | 2.9% +€1.7m | -3.8% | PS4.2x | |
| BST Biotechnology Assets | €0.34 | 4.9% +€1.0m | -18.3% | PS6.5x |
